Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Dr. Jun  Ma Ph.D.

President, Chief Executive Officer & Director

Mr. Michael J. Beecher CPA, CPA

Co-Chief Financial Officer & Secretary

Ms. Jane  Moen

President of VasoHealthcare & Director

Mr. Shen  Qiuming

President of Biox Instruments Co Ltd

Mr. Jonathan P. Newton

Co-Chief Financial Officer & Treasurer

Mr. Peter C. Castle

Chief Operating Officer

Mr. Randy  Hill

Consultant

Dr. Derek  Enlander M.D.

Advisor

Vaso Corporation

Vaso Corporation 管理结构

管理层信息